Jackson Creek Investment Advisors LLC Merck & Co., Inc. Transaction History

Jackson Creek Investment Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$123.8 - $132.96 $3,590 - $3,855	29 Added 0.84%	3,485 $431,000
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $2,831 - $3,298	-25 Reduced 0.72%	3,456 $456,000
Q4 2023 Feb 05, 2024	SELL	$100.18 - $109.02 $1,703 - $1,853	-17 Reduced 0.49%	3,481 $379,000
Q3 2023 Nov 03, 2023	SELL	$102.95 - $114.33 $409,638 - $454,919	-3,979 Reduced 53.22%	3,498 $360,000
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $812,076 - $885,127	7,477 New	7,477 $863,000
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $32,440 - $41,592	-371 Reduced 5.82%	6,006 $666,000
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $100,590 - $113,002	1,190 Added 22.94%	6,377 $549,000
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $433,062 - $490,897	5,187 New	5,187 $463,000
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $214,428 - $240,360	-2,917 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $210,840 - $264,105	2,917 New	2,917 $224,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.